KALA
Kala Pharmaceuticals Inc
Price:  
6.21 
USD
Volume:  
48,477.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KALA WACC - Weighted Average Cost of Capital

The WACC of Kala Pharmaceuticals Inc (KALA) is 5.5%.

The Cost of Equity of Kala Pharmaceuticals Inc (KALA) is 7.55%.
The Cost of Debt of Kala Pharmaceuticals Inc (KALA) is 5.00%.

Range Selected
Cost of equity 6.30% - 8.80% 7.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 6.1% 5.5%
WACC

KALA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.52 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1.09 1.09
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 6.1%
Selected WACC 5.5%